PHARMACOKINETICS IN SPECIAL POPULATIONS
Benefit from our long and relevant experience to create the most efficient study design, and quickly fill the panel with the special population to meet your objectives. We design, conduct, analyze, and report on pharmacokinetic studies in special populations, either as stand-alone studies or cohorts within larger, healthy normal volunteer studies.
We know it is often vital, depending on the indication, for safety and efficacy to observe the pharmacokinetics in different BMIs, genders, or ages. We have the team in place to overcome the challenge of recruiting healthy participants without conflicting concomitant medications, or populations with higher BMIs, or increasing age.
The recruiting teams across our clinics have robust databases to work from, with over 400,000 participants, and are also experts at participant outreach to continually add to our database. We deliver the patient access and relevant expertise you need.
Consult our Special and Patient Populations Fact Sheet
- Otherwise healthy populations based on age, gender, genotype, BMI
PARTICIPANTS IN OUR
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.